Keywords: liraglutide, gives, better, control, lantus, shares, novo

Liraglutide gives better control than Lantus

Article | 02 July 2007

Print This

Shares in Novo Nordisk jumped 5.9% to $106.98 on June 21 after the Danish diabetes specialist reported strong late-stage study data on its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in